×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
技术生物与农业工程研... [6]
中科院强磁场科学中心 [3]
中科院等离子体物理研... [2]
作者
刘青松 [2]
林涛 [1]
李红 [1]
亓爽 [1]
吴李君 [1]
许安 [1]
更多...
发表日期
2023 [1]
2022 [6]
2021 [2]
2020 [1]
2019 [1]
2017 [3]
更多...
语种
英语 [13]
出处
ACTA PHARM... [1]
BLOOD ADVA... [1]
BMC CANCER [1]
CANCER BIO... [1]
CANCER IMM... [1]
CANCERS [1]
更多...
资助项目
BeiGene [1]
BeiGene Co... [1]
CASHIPS Di... [1]
CASHIPS Di... [1]
CASHIPS Di... [1]
Cancer Res... [1]
更多...
资助机构
National N... [3]
Natural Sc... [2]
11575232) [1]
BeiGene [1]
BeiGene Co... [1]
CASHIPS Di... [1]
更多...
收录类别
SCI [13]
摘要
文献类型
期刊论文 [15]
学位论文 [6]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共21条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
期刊影响因子升序
期刊影响因子降序
题名升序
题名降序
WOS被引频次升序
WOS被引频次降序
提交时间升序
提交时间降序
发表日期升序
发表日期降序
作者升序
作者降序
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:
Bachy, Emmanuel
;
Savage, Kerry J.
;
Huang, Huiqiang
;
Kwong, Yok-Lam
;
Gritti, Giuseppe
;
Zhang, Qingyuan
;
Liberati, Anna Marina
;
Cao, Junning
;
Yang, Haiyan
;
Hao, Siguo
;
Hu, Jianda
;
Zhou, Keshu
;
Petrini, Mario
;
Russo, Filomena
;
Zhang, Huilai
;
Sang, Wei
;
Ji, Jie
;
Ferreri, Andres Jose Maria
;
Damaj, Gandhi Laurent
;
Liu, Hui
;
Zhang, Wei
;
Ke, Xiaoyan
;
Ghiggi, Chiara
;
Huang, Sha
;
Li, Xiaotong
;
Yao, Hui
;
Paik, Jason
;
Noveotny, William
;
Zhou, Wenxiao
;
Zhu, Hongji
;
Zinzani, Pier Luigi
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2023/11/10
Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Hu, Shumin
;
Gong, Jiali
;
Zhu, Xiu
;
Lu, Hongyang
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2022/12/23
Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Wang, Zuo-wei
;
Zou, Feng-ming
;
Wang, Ao-li
;
Yang, Jing
;
Jin, Rui
;
Wang, Bei-lei
;
Shen, Li-juan
;
Qi, Shuang
;
Liu, Juan
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2022/12/22
AZD4547
RIPK1
inhibitors
SIRS model
anti-necroptosis
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
;
Zhu, Liang
;
Sheng, Jiamin
;
Zhou, Zichao
;
Fan, Yun
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
;
Chen, Huafei
;
Xu, Chunwei
;
Zhang, Xiaoyan
;
Yuan, Hongling
;
Lou, Guangyuan
;
Shao, Lan
;
Zhang, Gu
;
Song, Zhengbo
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Lin, Yuxin
;
Zhu, Wei
;
Wu, Bingchen
;
Lan, Huiyin
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/05/16
Sarcoid-like reaction
immune checkpoint inhibitor
Toripalimab
PD-1
case report
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Chen, Xi
;
Kong, Haiying
;
Luo, Linxiang
;
Han, Shuiyun
;
Lei, Tao
;
Yu, Haifeng
;
Guo, Na
;
Li, Cong
;
Peng, Shuailing
;
Dong, Xiaowu
;
Yang, Haiyan
;
Wu, Meijuan
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2022/02/14
Hodgkin lymphoma
PD-1 inhibitor
PD-L1 inhibitor
PD-L2
Molecular phenotype
Tumor microenvironment
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Zhang, Xiangyu
;
Zeng, Liang
;
Li, Yizhi
;
Xu, Qinqin
;
Yang, Haiyan
;
Lizaso, Analyn
;
Mao, Xinru
;
Jin, Ren'an
;
Zeng, Yu
;
Li, Qinglin
;
Wang, Jianbo
;
Li, Yang
;
Zhang, Yongchang
;
Yang, Nong
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2021/03/15
Anlotinib
Immunotherapy
Programmed death 1 inhibitor
Lung cancer
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:
Shen, Dijian
;
Chen, Qixun
;
Wu, Jie
;
Li, Jianqiang
;
Tao, Kaiyi
;
Jiang, Youhua
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2021/04/26
Neoadjuvant immunotherapy
esophageal squamous cell carcinoma (ESCC)
thoracic surgery
programmed death 1 (PD-1)
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Wei, Qing
;
Yuan, Xing
;
Li, Jingjing
;
Xu, Qi
;
Ying, Jieer
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2020/11/30
Programmed death 1 (PD-1)
gastric cancer (GC)
immune checkpoint inhibitors
immunotherapy
apatinib